| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |